Immunization
Reports from Novartis advance knowledge in immunization
Published in Vaccine Weekly, January 30th, 2008
"Hence, we have a significant amount of clinical data to establish its potency and safety. We can now reassess our early preclinical studies and determine whether or not they were useful to predict human responses," wrote D.T. Ohagan and colleagues, Novartis.
The researchers concluded: "The main lesson learned is that mouse models can be valuable, but one must ask the right questions and the models must be used appropriately."
Ohagan and colleagues published their study in Clinical Pharmacology &...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2008-01-30)
More Articles from Vaccine Weekly
- HIV/AIDS
Keeping young South Africans in school: A 'social vaccine' against AIDS - HIV/AIDS
Uncovering the Achilles' heel of the HIV-1 envelope - HIV/AIDS
Study findings from Emory University, Emory Vaccine Center provide new insights into HIV/AIDS - Human Papillomavirus
New findings from Korea University describe advances in human papillomavirus - Immunization
Reports by V.E.J.C. Schijns and co-researchers describe recent advances in immunization - The Children's Hospital of Philadelphia
Medicaid Reimbursement for Car Seats Is Cost-Effective Health Policy - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
